← 返回

名称有何意义?用于肿瘤免疫治疗的记忆 NK 细胞

英文原题:What's in a name? Memory NK cells for cancer immunotherapy.

查看英文原题

What's in a name? Memory NK cells for cancer immunotherapy.

PubMed 2025/01/31(内容时间) J Immunother Cancer Q1 · IF 11.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞能够保留先前刺激和病原体暴露所形成的“记忆”特征,这一发现是一项里程碑式进展,凸显了先天免疫系统中的 NK 细胞与适应性免疫系统中的 T 细胞相似的诸多方面之一。这种“记住”先前刺激从而增强对宿主保护的能力,引发了人们对潜在治疗应用的极大兴趣。然而,初始 NK 细胞和记忆 NK 细胞在多大程度上重现 T 细胞的特征仍不清楚。尽管如此,尽管关于初始 NK 细胞和记忆 NK 细胞免疫生物学的问题尚未解决,将记忆 NK 细胞应用于临床以治疗癌症及其他适应证,已逐渐加快发展,以满足对新型免疫疗法尚未满足的需求。Arellano-Ballestero 等人最近的工作凸显了这一不断发展的领域以及记忆 NK 细胞当前的最新进展。这些细胞在临床中的应用正取得有前景的结果,但关于定义记忆 NK 细胞的关键分子、表型和功能特征,仍存在重要问题。

展开英文摘要原文

The discovery that natural killer (NK) cells can retain features of "memory" from previous stimulation and pathogen exposure was a landmark advance highlighting one of many ways in which NK cells of the innate immune system resemble T cells of the adaptive immune system. This ability to "remember" prior stimulation to bring about enhanced protection of the host sparked significant excitement regarding potential therapeutic applications. Yet, how closely the features of na ve and memory NK cells recapitulate those of T cells remains unclear.

Nonetheless, despite unresolved questions about the immunobiology of na ve and memory NK cells, the application of memory NK cells to the clinic for cancer and other indications has gathered steam to meet the unmet need for novel immunotherapies.

Recent work from Arellano-Ballestero et al highlights this evolving field and the current state of the art with memory NK cells. Application of these cells to the clinic is progressing with promising results, but important questions remain about the essential molecular, phenotypic, and functional characteristics that define a memory NK cell.

论文信息

作者
Judge SJ、Purl MC、Murphy WJ、Canter RJ
第一作者单位
Division of Surgical Oncology, Department of Surgery, University of California Davis School of Medicine, Sacramento, California, USA.United States
通讯作者单位
Division of Surgical Oncology, Department of Surgery, University of California Davis School of Medicine, Sacramento, California, USA rjcanter@ucdavis.edu.United States
期刊
Journal for immunotherapy of cancer2025 Jan 31
原文标识
PubMed 39890423 · DOI 10.1136/jitc-2024-010850